For research and educational purposes only. Not medical advice.
Cotadutide Reference
Educational, not medical advice reference for Cotadutide: GLP-1, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also known…
Reference summary
Phase 2 and Phase 3 trial data exist; pepSmart displays cotadutide only as trial-context educational content.
- Categories
- GLP-1, Fat Loss
- Aliases
- MEDI0382, GLP-1/glucagon dual agonist
- Evidence posture
- human — Human trial data exist, but cotadutide remains investigational — no FDA-approved drug label.
- Regulatory status
- Investigational. Cotadutide is a GLP-1 / glucagon dual receptor agonist in AstraZeneca Phase 3 programs in metabolic dysfunction-associated steatohepatitis (MASH/NASH). There is no FDA-approved drug label.
- Content review status
- investigational verified